Region/age groups | 18–20 years | 21–24 years | 25–29 years | ⩾30 years | p Value* | ||||
---|---|---|---|---|---|---|---|---|---|
% | (n/No) | % | (n/No) | % | (n/No) | % | (n/No) | ||
HIV-1, human immunodeficiency virus type 1; MSM, men who have sex with men. | |||||||||
In parentheses are number of HIV positive (n)/total number participants tested (No). | |||||||||
Denominator totals varied slightly because of missing data. | |||||||||
*By χ2 for trend. | |||||||||
Andean Region | |||||||||
Colombia | 13.9 | (11/79) | 16.2 | (24/148) | 17.6 | (29/165) | 24.5 | (57/233) | 0.015 |
Ecuador | 11.1 | (14/126) | 11.9 | (20/168) | 23.2 | (29/125) | 20.4 | (41/201) | 0.005 |
Peru | 5.0 | (120/2410) | 10.4 | (284/2727) | 14.6 | (334/2295) | 16.0 | (415/2586) | <0.001 |
Bolivia | 11.6 | (8/69) | 19.6 | (19/97) | 18.0 | (11/61) | 35.6 | (21/59) | 0.002 |
Southern Cone | |||||||||
Argentina | 1.7 | (1/60) | 5.7 | (9/157) | 14.8 | (30/203) | 16.0 | (60/376) | <0.001 |
Uruguay | 4.7 | (3/64) | 8.0 | (6/75) | 20.2 | (18/89) | 22.6 | (43/190) | <0.001 |
Paraguay | 11.1 | (3/27) | 11.1 | (3/27) | 13.0 | (3/20) | 20.0 | (3/15) | 0.471 |